117 related articles for article (PubMed ID: 22260899)
1. Neospora caninum: in vivo and in vitro treatment with artemisone.
Mazuz ML; Haynes R; Shkap V; Fish L; Wollkomirsky R; Leibovich B; Molad T; Savitsky I; Golenser J
Vet Parasitol; 2012 Jun; 187(1-2):99-104. PubMed ID: 22260899
[TBL] [Abstract][Full Text] [Related]
2. NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum.
Strohbusch M; Müller N; Hemphill A; Greif G; Gottstein B
Parasitology; 2008 Aug; 135(9):1065-73. PubMed ID: 18549517
[TBL] [Abstract][Full Text] [Related]
3. Synergic in vitro combinations of artemisinin, pyrimethamine and methylene blue against Neospora caninum.
Pereira LM; de Luca G; Abichabki NLM; Bronzon da Costa CM; Yatsuda AP
Vet Parasitol; 2018 Jan; 249():92-97. PubMed ID: 29279093
[TBL] [Abstract][Full Text] [Related]
4. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
5. Monensin use against Neospora caninum challenge in dairy cattle.
VanLeeuwen JA; Greenwood S; Clark F; Acorn A; Markham F; McCarron J; O'Handley R
Vet Parasitol; 2011 Feb; 175(3-4):372-6. PubMed ID: 21106293
[TBL] [Abstract][Full Text] [Related]
6. Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide.
Debache K; Guionaud C; Kropf C; Boykin D; Stephens CE; Hemphill A
Exp Parasitol; 2011 Oct; 129(2):95-100. PubMed ID: 21803039
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiprotozoal effects of artemisinin on Neospora caninum.
Kim JT; Park JY; Seo HS; Oh HG; Noh JW; Kim JH; Kim DY; Youn HJ
Vet Parasitol; 2002 Jan; 103(1-2):53-63. PubMed ID: 11751000
[TBL] [Abstract][Full Text] [Related]
8. Confirmed clinical Neospora caninum infection in a boxer puppy from Argentina.
Basso W; Venturini MC; Bacigalupe D; Kienast M; Unzaga JM; Larsen A; Machuca M; Venturini L
Vet Parasitol; 2005 Aug; 131(3-4):299-303. PubMed ID: 15978728
[TBL] [Abstract][Full Text] [Related]
9. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
Alaeddine F; Keller N; Leepin A; Hemphill A
J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts.
Müller J; Balmer V; Winzer P; Rahman M; Manser V; Haynes RK; Hemphill A
Int J Antimicrob Agents; 2015 Jul; 46(1):88-93. PubMed ID: 25934265
[TBL] [Abstract][Full Text] [Related]
11. Gerbil model of acute neosporosis.
Ramamoorthy S; Sriranganathan N; Lindsay DS
Vet Parasitol; 2005 Jan; 127(2):111-4. PubMed ID: 15631903
[TBL] [Abstract][Full Text] [Related]
12. Neospora caninum detected in feral rodents.
Jenkins MC; Parker C; Hill D; Pinckney RD; Dyer R; Dubey JP
Vet Parasitol; 2007 Jan; 143(2):161-5. PubMed ID: 16997474
[TBL] [Abstract][Full Text] [Related]
13. In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum.
Müller J; Aguado A; Laleu B; Balmer V; Ritler D; Hemphill A
Int J Parasitol; 2017 Oct; 47(12):801-809. PubMed ID: 28751177
[TBL] [Abstract][Full Text] [Related]
14. First isolation of Neospora caninum from the feces of a naturally infected dog.
Basso W; Venturini L; Venturini MC; Hill DE; Kwok OC; Shen SK; Dubey JP
J Parasitol; 2001 Jun; 87(3):612-8. PubMed ID: 11426726
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Neospora caninum and other intestinal protozoan parasites in populations of Swiss dogs.
Sager H; Moret CS; Müller N; Staubli D; Esposito M; Schares G; Hässig M; Stärk K; Gottstein B
Vet Parasitol; 2006 Jun; 139(1-3):84-92. PubMed ID: 16564131
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice.
Gottstein B; Eperon S; Dai WJ; Cannas A; Hemphill A; Greif G
Parasitol Res; 2001 Jan; 87(1):43-8. PubMed ID: 11199848
[TBL] [Abstract][Full Text] [Related]
17. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
Tuo W; Zhao Y; Zhu D; Jenkins MC
Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
[TBL] [Abstract][Full Text] [Related]
18. Viability of sporulated oocysts of Neospora caninum after exposure to different physical and chemical treatments.
Alves Neto AF; Bandini LA; Nishi SM; Soares RM; Driemeier D; Antoniassi NA; Schares G; Gennari SM
J Parasitol; 2011 Feb; 97(1):135-9. PubMed ID: 21348620
[TBL] [Abstract][Full Text] [Related]
19. Improved production of Neospora caninum oocysts, cyclical oral transmission between dogs and cattle, and in vitro isolation from oocysts.
Gondim LF; Gao L; McAllister MM
J Parasitol; 2002 Dec; 88(6):1159-63. PubMed ID: 12537111
[TBL] [Abstract][Full Text] [Related]
20. Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites.
Debache K; Hemphill A
Parasitology; 2012 Jun; 139(7):934-44. PubMed ID: 22309643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
